WALLIS MOLCHEN to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications WALLIS MOLCHEN has written about Randomized Controlled Trials as Topic.
Connection Strength
0.090
-
Automated summaries of serious adverse events in the hepatitis C antiviral long-term treatment against cirrhosis trial. Clin Trials. 2009 Dec; 6(6):618-27.
Score: 0.057
-
Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial. Hepatology. 2011 Nov; 54(5):1527-37.
Score: 0.033